What is the recommended acute management for a patient with Prinzmetal (variant) angina presenting with ST‑segment elevation myocardial infarction (STEMI)?

Prinzmetal Angina Presenting as STEMI: Acute Management

In a patient with suspected Prinzmetal (vasospastic) angina presenting with ST-segment elevation, immediate coronary angiography is essential to differentiate true thrombotic STEMI from coronary vasospasm, as the treatments diverge dramatically—avoid fibrinolysis and instead administer intracoronary or intravenous nitroglycerin to relieve spasm, followed by calcium channel blockers and long-acting nitrates for definitive therapy.

Critical Initial Distinction

The fundamental challenge is that Prinzmetal angina can present identically to atherothrombotic STEMI with ST-segment elevation, chest pain, and positive troponins 1, 2, 3. However, the underlying pathophysiology—reversible coronary vasospasm versus fixed thrombotic occlusion—demands completely different management strategies.

Immediate Diagnostic Approach

Proceed directly to emergency coronary angiography rather than empiric fibrinolysis when Prinzmetal angina is suspected 4. Key clinical clues suggesting vasospasm include:

• Recurrent episodes of chest pain with transient ST-elevation that resolve spontaneously 2, 5
• Pain occurring at rest, particularly in early morning hours
• Younger patients without traditional atherosclerotic risk factors 2
• History of migraine or use of vasoconstrictive medications 6
• Previous episodes with documented normal coronaries

Acute Management Algorithm

Step 1: Immediate Pharmacologic Intervention

Administer sublingual or intravenous nitroglycerin immediately upon presentation 7, 5. This serves dual purposes:

• Therapeutic relief of vasospasm
• Diagnostic test—rapid resolution of ST-elevation and symptoms strongly suggests vasospasm 2

Step 2: Emergency Angiography

Transfer to catheterization laboratory emergently as you would for any STEMI presentation 4. The 2017 ESC STEMI guidelines recommend reperfusion therapy for all patients with symptoms <12 hours and persistent ST-elevation 4.

During angiography:

• If vasospasm is visualized (focal or diffuse narrowing without fixed stenosis), administer intracoronary nitroglycerin 2, 3
• Document resolution of spasm angiographically—this confirms the diagnosis
• If thrombotic occlusion is present, proceed with standard primary PCI per guidelines 4

Step 3: Avoid Fibrinolysis

Critical caveat: Do NOT administer fibrinolytic therapy if Prinzmetal angina is suspected, even with ST-elevation. The ESC guidelines recommend fibrinolysis only when primary PCI cannot be performed timely 4. However, fibrinolysis is contraindicated in vasospastic angina as:

• No thrombus exists to lyse
• Exposes patient to unnecessary bleeding risk
• Delays definitive diagnosis and appropriate therapy

Definitive Medical Therapy

Once vasospasm is confirmed:

Primary Agents (Class I Evidence for Vasospastic Angina)

Calcium channel blockers are the cornerstone of therapy 7, 8, 5:

• Diltiazem 240 mg daily or equivalent dose of other calcium antagonists
• Demonstrated 90% reduction in anginal episodes 7
• Superior to other vasodilators due to sustained effect and tolerability

Long-acting nitrates as adjunctive therapy 7, 5:

• Isosorbide mononitrate for prophylaxis
• Sublingual nitroglycerin for acute episodes

Agents to Avoid

Beta-blockers should be avoided or used with extreme caution in pure vasospastic angina, as unopposed alpha-adrenergic stimulation may paradoxically worsen coronary spasm 5. This contrasts sharply with standard post-STEMI care where beta-blockers are Class I recommended 4.

Post-Diagnosis Management

If True STEMI is Confirmed (Thrombotic Occlusion)

Follow standard ESC STEMI guidelines 4:

• Dual antiplatelet therapy: Aspirin plus ticagrelor or prasugrel for 12 months (Class I, Level A)
• High-intensity statin initiated immediately (Class I, Level A)
• ACE inhibitor within 24 hours if heart failure, LV dysfunction, diabetes, or anterior infarct (Class I, Level A)
• Beta-blocker for heart failure or LVEF <40% (Class I, Level A)

If Vasospastic Angina is Confirmed

• Calcium channel blocker (mandatory, not optional)
• Long-acting nitrate
• Avoid beta-blockers unless compelling indication
• Consider alpha-blocker if refractory, though side effects limit use 7
• Identify and eliminate triggers (smoking, cocaine, vasoconstrictive medications) 6, 5

Common Pitfalls

1. Assuming all ST-elevation requires fibrinolysis: This can be catastrophic in vasospastic angina—always consider angiography first when feasible
2. Prescribing beta-blockers reflexively: Standard post-MI protocols may worsen vasospasm
3. Missing recurrent patterns: Patients with Prinzmetal angina often have multiple ED visits labeled as "atypical chest pain" before diagnosis 2, 3
4. Inadequate calcium channel blocker dosing: Therapeutic doses (e.g., diltiazem 240 mg daily) are required for efficacy 7

Prognosis Considerations

Vasospastic angina is not benign—it carries risk of acute MI, ventricular arrhythmias, and sudden cardiac death 6, 5, 3. However, with appropriate calcium channel blocker therapy, prognosis is generally favorable. The key is establishing the correct diagnosis through angiography and avoiding inappropriate treatments like fibrinolysis or beta-blockade that may worsen outcomes.